Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost
Background: A significant blood loss may be encountered with complex urethroplasty surgery. Blood management aims at reducing allogeneic blood transfusion (ABT) because of limited supply, associated risks, and cost. Intraoperative cell salvage (ICS) has been used in different urological and nonurolo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Urology Annals |
| Subjects: | |
| Online Access: | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2022;volume=14;issue=4;spage=377;epage=382;aulast=Altaweel |
| _version_ | 1828098753849982976 |
|---|---|
| author | Waleed Altaweel Shahbaz Mehmood Raouf Seyam |
| author_facet | Waleed Altaweel Shahbaz Mehmood Raouf Seyam |
| author_sort | Waleed Altaweel |
| collection | DOAJ |
| description | Background: A significant blood loss may be encountered with complex urethroplasty surgery. Blood management aims at reducing allogeneic blood transfusion (ABT) because of limited supply, associated risks, and cost. Intraoperative cell salvage (ICS) has been used in different urological and nonurological surgeries to achieve this goal. However, no study evaluated its role in perineal urethroplasty.
Objectives: We set out to determine the efficacy of reducing ABT, safety, and cost of ICS in posterior urethroplasty.
Methods: We reviewed the charts of all patients who underwent posterior urethroplasty between 2012 and 2017. We collected data for patients' demographics, pre- and postoperative hemoglobin level, ICS volume, complications, equivalent ABT units saved, and cost.
Results: Seventy patients with a median age of 27.5 ± 10.2 years underwent posterior urethroplasty. Of the 70 patients, 20 (28.57%) required ICS intraoperatively with a median of 441 ml/patient, equivalent to 1.47 units per patient of allogenic blood. No patient needed intraoperative ABT, whereas two patients required transfusions postoperatively. The median pre- and postoperative hemoglobin levels were 124.2 ± 9.2 and 110.3 ± 12.6 g/dl, respectively. There were no significant complications noted while using ICS. There was a 41% cost reduction of equivalent ABT units.
Conclusions: ICS is safe and effective in reducing ABT during posterior urethroplasty. In our hospital, it is associated with a significant cost reduction of blood transfusion. |
| first_indexed | 2024-04-11T08:06:00Z |
| format | Article |
| id | doaj.art-76fd8d9294064308a1b32831f2d67b07 |
| institution | Directory Open Access Journal |
| issn | 0974-7796 0974-7834 |
| language | English |
| last_indexed | 2024-04-11T08:06:00Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Urology Annals |
| spelling | doaj.art-76fd8d9294064308a1b32831f2d67b072022-12-22T04:35:32ZengWolters Kluwer Medknow PublicationsUrology Annals0974-77960974-78342022-01-0114437738210.4103/ua.ua_119_21Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and costWaleed AltaweelShahbaz MehmoodRaouf SeyamBackground: A significant blood loss may be encountered with complex urethroplasty surgery. Blood management aims at reducing allogeneic blood transfusion (ABT) because of limited supply, associated risks, and cost. Intraoperative cell salvage (ICS) has been used in different urological and nonurological surgeries to achieve this goal. However, no study evaluated its role in perineal urethroplasty. Objectives: We set out to determine the efficacy of reducing ABT, safety, and cost of ICS in posterior urethroplasty. Methods: We reviewed the charts of all patients who underwent posterior urethroplasty between 2012 and 2017. We collected data for patients' demographics, pre- and postoperative hemoglobin level, ICS volume, complications, equivalent ABT units saved, and cost. Results: Seventy patients with a median age of 27.5 ± 10.2 years underwent posterior urethroplasty. Of the 70 patients, 20 (28.57%) required ICS intraoperatively with a median of 441 ml/patient, equivalent to 1.47 units per patient of allogenic blood. No patient needed intraoperative ABT, whereas two patients required transfusions postoperatively. The median pre- and postoperative hemoglobin levels were 124.2 ± 9.2 and 110.3 ± 12.6 g/dl, respectively. There were no significant complications noted while using ICS. There was a 41% cost reduction of equivalent ABT units. Conclusions: ICS is safe and effective in reducing ABT during posterior urethroplasty. In our hospital, it is associated with a significant cost reduction of blood transfusion.http://www.urologyannals.com/article.asp?issn=0974-7796;year=2022;volume=14;issue=4;spage=377;epage=382;aulast=Altaweelallogenic blood transfusioncostintraoperative cell salvage transfusionperineal urethroplasty |
| spellingShingle | Waleed Altaweel Shahbaz Mehmood Raouf Seyam Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost Urology Annals allogenic blood transfusion cost intraoperative cell salvage transfusion perineal urethroplasty |
| title | Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost |
| title_full | Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost |
| title_fullStr | Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost |
| title_full_unstemmed | Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost |
| title_short | Intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty: Its efficacy of reducing allogeneic blood transfusion, safety, and cost |
| title_sort | intraoperative cell salvage transfusion in patients undergoing posterior urethroplasty its efficacy of reducing allogeneic blood transfusion safety and cost |
| topic | allogenic blood transfusion cost intraoperative cell salvage transfusion perineal urethroplasty |
| url | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2022;volume=14;issue=4;spage=377;epage=382;aulast=Altaweel |
| work_keys_str_mv | AT waleedaltaweel intraoperativecellsalvagetransfusioninpatientsundergoingposteriorurethroplastyitsefficacyofreducingallogeneicbloodtransfusionsafetyandcost AT shahbazmehmood intraoperativecellsalvagetransfusioninpatientsundergoingposteriorurethroplastyitsefficacyofreducingallogeneicbloodtransfusionsafetyandcost AT raoufseyam intraoperativecellsalvagetransfusioninpatientsundergoingposteriorurethroplastyitsefficacyofreducingallogeneicbloodtransfusionsafetyandcost |